TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.2, pp.324-329, 2020 (SCI-Expanded)
Background/aim: Crohn's disease (CD) is a kind of inflammatory bowel disease. Midkine (MDK) is an endogenous inflammatory marker. We aimed to investigate the relationship between MDK levels and inflammation and hence determine whether MDK can be used as a noninvasive biomarker in active CD.